These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11815622)

  • 1. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
    Aoukaty A; Tan R
    J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
    J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective NK cell activation in X-linked lymphoproliferative disease.
    Benoit L; Wang X; Pabst HF; Dutz J; Tan R
    J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
    Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
    Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.
    Chen R; Relouzat F; Roncagalli R; Aoukaty A; Tan R; Latour S; Veillette A
    Mol Cell Biol; 2004 Jun; 24(12):5144-56. PubMed ID: 15169881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease.
    Aoukaty A; Tan R
    J Immunol; 2005 Apr; 174(8):4551-8. PubMed ID: 15814676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).
    Eissmann P; Beauchamp L; Wooters J; Tilton JC; Long EO; Watzl C
    Blood; 2005 Jun; 105(12):4722-9. PubMed ID: 15713798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP.
    Tangye SG; Lazetic S; Woollatt E; Sutherland GR; Lanier LL; Phillips JH
    J Immunol; 1999 Jun; 162(12):6981-5. PubMed ID: 10358138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
    Nakajima H; Colonna M
    Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis.
    Meazza R; Tuberosa C; Cetica V; Falco M; Parolini S; Grieve S; Griffiths GM; Sieni E; Marcenaro S; Micalizzi C; Montin D; Fagioli F; Moretta A; Mingari MC; Moretta L; Notarangelo LD; Bottino C; Aricò M; Pende D
    J Allergy Clin Immunol; 2014 Dec; 134(6):1381-1387.e7. PubMed ID: 24985396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse.
    Roda-Navarro P; Mittelbrunn M; Ortega M; Howie D; Terhorst C; Sánchez-Madrid F; Fernández-Ruiz E
    J Immunol; 2004 Sep; 173(6):3640-6. PubMed ID: 15356108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
    Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
    J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP.
    Sayós J; Martín M; Chen A; Simarro M; Howie D; Morra M; Engel P; Terhorst C
    Blood; 2001 Jun; 97(12):3867-74. PubMed ID: 11389028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WhatSAP - 2B4 sends mixed messages in the absence of SAP.
    Watzl C; Claus M
    Eur J Immunol; 2014 May; 44(5):1281-4. PubMed ID: 24659462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
    Schuster V; Kreth HW
    Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity.
    Nakajima H; Cella M; Bouchon A; Grierson HL; Lewis J; Duckett CS; Cohen JI; Colonna M
    Eur J Immunol; 2000 Nov; 30(11):3309-18. PubMed ID: 11093147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
    Dupré L; Andolfi G; Tangye SG; Clementi R; Locatelli F; Aricò M; Aiuti A; Roncarolo MG
    Blood; 2005 Jun; 105(11):4383-9. PubMed ID: 15677558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.
    Morra M; Simarro-Grande M; Martin M; Chen AS; Lanyi A; Silander O; Calpe S; Davis J; Pawson T; Eck MJ; Sumegi J; Engel P; Li SC; Terhorst C
    J Biol Chem; 2001 Sep; 276(39):36809-16. PubMed ID: 11477068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.